Most senior healthcare executives agreed that a healthcare system that embraces transparency will produce safer care and better outcomes, but a minority are happy with the current degree of transparency in their organization.
Most senior healthcare executives (93%) agreed that a healthcare system that embraces transparency will produce safer care and better outcomes, according to the poll results of the National Patient Safety Foundation’s (NPSF) annual Patient Safety Congress. However, only 22% said they were satisfied with the degree of transparency in their organization.
According to the NPSF, making transparency part of routine practice starts with focusing on the relationship between clinicians and patients, and it has developed a series of best practice approaches and educational opportunities specific to Communication and Resolution Programs.
“Transparency is essential if professionals and organizations are to learn from mistakes and implement practices to keep them from recurring,” note Tejal K. Gandhi, MD, MPH, CPPS, and Patricia McTiernan, MS, of the NPSF, writing in “A Necessary Step to Safer Care,” published online in Inside Medical Liability.
The domains where transparency must become part of routine practice include:
NPSF acknowledges there are barriers that prevent greater openness, such as the fear of litigation and concerns about damage to a provider’s or organization’s reputation when something goes wrong. However, the report points out that these fears are unfounded, according to organizations that have pursued greater transparency.
“While clinical care is an important focus for expanding openness, it is only one area of healthcare where greater transparency is needed,” the authors concluded. “If we really want to lead through learning, we must move toward greater transparency among clinicians through peer review or other mechanisms; among organizations through regional or national collaboratives; and with the public, through reporting of useful quality and safety metrics.”
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More